Gilson Costa Macedo

Gilson Costa Macedo

Auto-generated profile, based on publicly available information

Gilson Costa Macedo

Department of Parasitology, Microbiology, and Immunology, Institute of Biological Sciences, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2006 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
PCPatricia Cardoso
Patricia Cardoso
GMGilson Costa Macedo
Gilson Costa Macedo
Vasco AzevedoVasco Azevedo
Vasco Azevedo
Sergio Costa OliveiraSergio Costa Oliveira
Sergio Costa Oliveira
Brucella spp. are facultative intracellular pathogens that have the ability to survive and multiply in professional and non-professional phagocytes, and cause abortion in domestic animals and undulant fever in humans. Several species are recognized within the genusBrucellaand this classification is mainly based on the difference in pathogenicity and in host preference.Brucellastrains may occur as either smooth or rough, expressing smooth LPS (S-LPS) or rough LPS (R-LPS) as major surface antigen. This bacterium possesses an unconventional non-endotoxic lipopolysaccharide that confers resistance to anti-microbial attacks and modulates the host immune response. The strains that are pathogenic for humans (B. abortus,B. suis,B. melitensis) carry a smooth LPS involved in the virulence of these bacteria. The LPS O-chain protects the bacteria from cellular cationic peptides, oxygen metabolites and complement-mediated lysis and it is a key molecule forBrucellasurvival and replication in the host. Here, we review i)BrucellaLPS structure; ii)Brucellagenome, iii) genes involved in LPS biosynthesis; iv) the interaction between LPS and innate immunity.

1 October 2008 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
Fernanda C. CardosoFernanda C. Cardoso
Fernanda C. Cardoso
GMGilson C Macedo
Gilson C Macedo
EGElisandra Gava
Elisandra Gava
GKGregory T Kitten
Gregory T Kitten
VMVitor L Mati
Vitor L Mati
Sergio Costa OliveiraSergio Costa Oliveira
Sergio Costa Oliveira
Schistosomiasis continues to be a significant public health problem. This disease affects 200 million people worldwide and almost 800 million people are at risk of acquiring the infection. Although vaccine development against this disease has experienced more failures than successes, encouraging results have recently been obtained using membrane-spanning protein antigens from the tegument of Schistosoma mansoni. Our group recently identified Sm29, another antigen that is present at the adult worm tegument surface. In this study, we investigated murine cellular immune responses to recombinant (r) Sm29 and tested this protein as a vaccine candidate. We first show that Sm29 is located on the surface of adult worms and lung-stage schistosomula through confocal microscopy. Next, immunization of mice with rSm29 engendered 51%, 60% and 50% reduction in adult worm burdens, in intestinal eggs and in liver granuloma counts, respectively (p<0.05). Protective immunity in mice was associated with high titers of specific anti-Sm29 IgG1 and IgG2a and elevated production of IFN-γ, TNF-α and IL-12, a typical Th1 response. Gene expression analysis of worms recovered from rSm29 vaccinated mice relative to worms from control mice revealed a significant (q<0.01) down-regulation of 495 genes and up-regulation of only 22 genes. Among down-regulated genes, many of them encode surface antigens and proteins associated with immune signals, suggesting that under immune attack schistosomes reduce the expression of critical surface proteins. This study demonstrates that Sm29 surface protein is a new vaccine candidate against schistosomiasis and suggests that Sm29 vaccination associated with other protective critical surface antigens is the next logical strategy for improving protection. Schistosomiasis is the most important human helminth infection in terms of morbidity and mortality. Although the efforts to develop a vaccine against this disease have experienced failures, a new generation of surface antigens revealed by proteomic studies changed this scenario. Our group has characterized the protein Sm29 described previously as one of the most exposed and expressed antigens in the outer tegument of Schistosoma mansoni. Studies in patients living in endemic areas for schistosomiasis revealed high levels of IgG1 and IgG3 anti-Sm29 in resistant individuals. In this study, confocal microscope analysis showed Sm29 present in the surface of lung-stage schistosoluma and adult worms. Recombinant Sm29, when used as vaccine candidate, induced high levels of protection in mice. This protection was associated with a typical Th1 immune response and reduction of worm burden, liver granulomas and in intestinal eggs. Further, microarray analysis of worms recovered from vaccinated mice showed significant down-regulation of several genes encoding previously characterized vaccine candidates and/or molecules exposed on the surface, suggesting an immune evasion strategy of schistosomes under immune attack. These results demonstrated that Sm29 as one of the important antigens with potential to compose a vaccine against schistosomiasis.

15 January 2008 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
GMGilson Costa Macedo
Gilson Costa Macedo
DMDiogo Matos Magnani
Diogo Matos Magnani
NCNatalia Barbosa Carvalho
Natalia Barbosa Carvalho
OBOscar Bruna-Romero
Oscar Bruna-Romero
RGRicardo T. Gazzinelli
Ricardo T. Gazzinelli
SOSergio Costa Oliveira
Sergio Costa Oliveira
Brucella abortus is a facultative intracellular bacterium that infects humans and domestic animals. The enhanced susceptibility to virulent B. abortus observed in MyD88 knockout (KO) mice led us to investigate the mechanisms involved in MyD88-dependent immune responses. First, we defined the role of MyD88 in dendritic cell (DC) maturation. In vitro as well as in vivo, B. abortus-exposed MyD88 KO DCs displayed a significant impairment on maturation as observed by expression of CD40, CD86, and MHC class II on CD11c+ cells. In addition, IL-12 and TNF-α production was totally abrogated in MyD88 KO DCs and macrophages. Furthermore, B. abortus-induced IL-12 production was found to be dependent on TLR2 in DC, but independent on TLR2 and TLR4 in macrophages. Additionally, we investigated the role of exogenous IL-12 and TNF-α administration on MyD88 KO control of B. abortus infection. Importantly, IL-12, but not TNF-α, was able to partially rescue host susceptibility in MyD88 KO-infected animals. Furthermore, we demonstrated the role played by TLR9 during virulent B. abortus infection. TLR9 KO-infected mice showed 1 log Brucella CFU higher than wild-type mice. Macrophages and DC from TLR9 KO mice showed reduced IL-12 and unaltered TNF-α production when these cells were stimulated with Brucella. Together, these results suggest that susceptibility of MyD88 KO mice to B. abortus is due to impaired DC maturation and lack of IL-12 synthesis. Additionally, DC activation during Brucella infection plays an important regulatory role by stimulating and programming T cells to produce IFN-γ.

1 January 2015 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
CMCarlos Magno da Costa Maranduba
Carlos Magno da Costa Maranduba
SCSandra Castro
Sandra Castro
GSGustavo Torres de Souza
Gustavo Torres de Souza
CRCristiano Rossato
Cristiano Rossato
FGFrancisco Carlos da Guia
Francisco Carlos da Guia
FSFernando de Sá Silva
Fernando de Sá Silva
Many immune-based intestinal disorders, such as ulcerative colitis and Crohn’s disease, as well as other illnesses, may have the intestines as an initial cause or aggravator in the development of diseases, even apparently not correlating directly to the intestine. Diabetes, obesity, multiple sclerosis, depression, and anxiety are examples of other illnesses discussed in the literature. In parallel, importance of the gut microbiota in intestinal homeostasis and immunologic conflict between tolerance towards commensal microorganisms and combat of pathogens is well known. Recent researches show that the immune system, when altered by the gut microbiota, influences the state in which these diseases are presented in the patient directly and indirectly. At the present moment, a considerable number of investigations about this subject have been performed and published. However, due to difficulties on correlating information, several speculations and hypotheses are generated. Thus, the present review aims at bringing together how these interactions work—gut microbiota, immune system, and their influence in the neuroimmune system.

1 July 2008 in Microbes and Infection
Verified
Journal Article
Closed access
Sergio Costa OliveiraSergio Costa Oliveira
Sergio Costa Oliveira
FOFernanda Souza de Oliveira
Fernanda Souza de Oliveira
GMGilson Costa Macedo
Gilson Costa Macedo
LALeonardo Augusto de Almeida
Leonardo Augusto de Almeida
NCNatalia Barbosa Carvalho
Natalia Barbosa Carvalho

11 December 2011 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
ABAna Paula M. S. Brandão
Ana Paula M. S. Brandão
FOFernanda S. Oliveira
Fernanda S. Oliveira
NCNatalia B. Carvalho
Natalia B. Carvalho
LVLeda Q. Vieira
Leda Q. Vieira
VAVasco Azevedo
Vasco Azevedo
Sergio Costa OliveiraSergio Costa Oliveira
Sergio Costa Oliveira
Brucella abortusis a facultative intracellular bacterial pathogen that causes abortion in domestic animals and undulant fever in humans. IFN-γ, IL-12, and CD8+ T lymphocytes are important components of host immune responses againstB. abortus. Herein, IFN-γand IL-12/β2-microglobulin (β2-m) knockout mice were used to determine whether CD8+ T cells and IL-12-dependent IFN-γdeficiency would be more critical to controlB. abortusinfection compared to the lack of endogenous IFN-γ. At 1 week after infection, IFN-γKO and IL-12/β2-m KO mice showed increased numbers of bacterial load in spleens; however, at 3 weeks postinfection (p.i.), only IFN-γKO succumbed toBrucella. All IFN-γKO had died at 16 days p.i. whereas death within the IL-12/β2-m KO group was delayed and occurred at 32 days until 47 days postinfection. Susceptibility of IL-12/β2-m KO animals toBrucellawas associated to undetectable levels of IFN-γin mouse splenocytes and inability of these cells to lyseBrucella-infected macrophages. However, the lack of endogenous IFN-γwas found to be more important to control brucellosis than CD8+ T cells and IL-12-dependent IFN-γdeficiencies.